Antibody-Drug Conjugate Safety Profiles in NSCLC

Opinion
Video

Edward B. Garon, MD, MS, reviews the safety profiles of sacituzumab govitecan and datopotamab deruxtecan in patients with non–small cell lung cancer.

Related Videos
Related Content